Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Allergy Clin Immunol. 2016 Apr 6;138(2):625–628.e2. doi: 10.1016/j.jaci.2016.01.048

IgE antibodies and response to cow's milk elimination diet in pediatric eosinophilic esophagitis

Elizabeth A Erwin 1,, Patrice G Kruszewski 2, John M Russo 3, Alexander J Schuyler 4, Thomas AE Platts-Mills 4
PMCID: PMC5448280  NIHMSID: NIHMS774162  PMID: 27113847

Summary

Milk is a common cause of eosinophilic esophagitis. Allergy testing does not predict response to dietary therapy. In this study, patients with low or undetectable IgE antibodies to milk achieved histologic remission with milk elimination.

Keywords: eosinophilic esophagitis, children, food allergens, IgE assay, dietary treatment, remission

To the Editor

There are three lines of evidence supporting cow's milk as a relevant problem food for pediatric patients with eosinophilic esophagitis (EoE). First, studies of the six-food elimination diet followed by reintroduction of food groups showed that when cow's milk was reintroduced, symptoms or inflammation returned in up to 74% of patients. Second, it was subsequently reported in a retrospective analysis that a significant proportion of EoE patients (65%) responded to single food elimination of cow's milk (1). In our own recent prospective study of patients treated with cow's milk elimination, we also found that 65% of patients had <15 eosinophils/high power field (hpf) after 6-8 weeks of treatment (2). Finally, a striking proportion of pediatric EoE patients have low levels of serum IgE antibodies to cow's milk (3). Our objective for the current analysis, was to evaluate the relationship between specific IgE antibodies to cow's milk, as well as other common problem foods, and histologic response after cow's milk elimination.

Through two separate studies, we have prospectively observed 27 patients who were treated with cow's milk elimination diet (2). In the first study, patients were treated with proton pump inhibitor (PPI) concurrently (2). Subsequent patients were treated with PPI prior to starting cow's milk elimination diet. Twenty-one patients had repeat upper endoscopy after 6-8 weeks of treatment to evaluate histologic response. Serum analysis for total IgE and specific IgE antibodies to cow's milk, egg, wheat, soy, and peanut was performed by ImmunoCAP (ThermoFisher Scientific/Phadia, Uppsala, Sweden). In nine patients, serum was available to perform additional studies and IgG4 antibodies to cow's milk and IgE antibodies to milk components were also measured by ImmunoCAP. We analyzed the categorical variables IgE antibodies to food (≥0.35 IU/ml) and histologic response (yes or no) using the chi square test, and after testing for normality, we compared geometric mean levels of IgE antibodies in “responders” and “non-responders” using the t test. Levels of IgG4 antibodies to cow's milk were analyzed using the Mann Whitney U test. Log ratios of IgG4/IgE antibodies to milk were compared using a paired t test.

Thirteen patients (62%) were classified as “responders” to dietary elimination of cow's milk based on having <15 eosinophils/hpf on repeat esophageal biopsy. Peak esophageal eosinophil counts decreased from a mean of 59 [standard deviation (SD) 35] to 6.3 (SD 4.8) in responders compared with a mean of 56 (SD 31) to 34 (SD 11) in nonresponders. Levels of specific IgE antibodies to cow's milk were <0.35 IU/ml for 8/13 responders (62%). In contrast, specific IgE antibodies to cow's milk were <0.35 IU/ml for 2/8 non-responders (25%) (p=0.1) (Table IA). The geometric mean level of specific IgE to cow's milk among patients with detectable IgE antibodies was significantly lower in responders at 0.50 IU/ml [95% confidence interval (CI) .32-1.0] versus 2.6 IU/ml (95% CI 1.6-5.1) in non-responders (p=0.002) (Table IB). Furthermore, there was a direct correlation between levels of IgE antibodies to milk and the number of esophageal eosinophils found after treatment (R=0.46, p=0.04) (Fig E1). Among the nine patients who had analysis for IgE to milk component allergens, 0/6 responders had detectable IgE antibodies to any specific milk protein compared with 3/3 non-responders. Patients who did not respond to single food elimination of cow's milk also had IgE antibodies to wheat (p=0.006) and egg (Table IB). All patients tested, including those without specific IgE to cow's milk, had IgG4 antibodies to milk [median level 1420 mgA/L (range 17.6-2010)]. Overall log ratios of IgG4/IgE antibodies to milk decreased significantly with cow's milk elimination diet from 3.0 to 2.6 (p=0.05). The change in ratios was not different in responders and nonresponders (p=0.7).

Table IA.

Levels of specific IgE antibody (IU/ml) to foods and distinct milk components at baseline.

Age (y) Gender Milk Bos d 4 Bos d 5 Bos d 8 Bos d 6 Egg Wheat Soy Peanut
Responders
 D001 13 M <0.10 nd nd nd nd <0.10 <0.10 <0.10 <0.10
 D015 2 F 0.43 0.29 <0.10 0.13 0.28 <0.10 <0.10 <0.10 <0.10
 D021 2 F <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
 D011 10 M 0.56 nd nd nd nd 0.33 33.2 26.0 18.5
 D020 5 F 1.26 <0.10 <0.10 0.12 <0.10 <0.10 <0.10 <0.10 <0.10
 D018 13 M 0.22 0.18 0.12 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
 D009 15 M <0.10 <0.10 <0.10 <0.10 <0.10 0.26 <0.10 <0.10 <0.10
 D010 15 F <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 0.17 <0.10 0.19
 D002 2 M <0.10 nd nd nd nd <0.10 <0.10 <0.10 <0.10
 Diet1 5 F 0.34 nd nd nd nd <0.10 <0.10 <0.10 <0.10
 Diet2 3 M 0.79 nd nd nd nd <0.10 0.17 0.14 nd
 Diet5 15 F 1.67 nd nd nd nd 0.25 0.24 0.11 nd
 Diet7 14 F 0.26 nd nd nd nd <0.10 0.35 0.18 0.21
Non-responders
 D007 16 M 3.65 2.67 2.88 2.08 0.56 0.30 0.82 0.40 0.26
 D013 14 M 2.53 2.37 0.60 0.75 0.43 0.17 0.39 <0.10 0.27
 D019 13 M 1.58 0.87 0.96 0.27 0.23 1.02 1.05 0.82 0.94
 D006 11 M <0.10 nd nd nd nd <0.10 <0.10 <0.10 <0.10
 D004 15 M 1.53 nd nd nd nd 0.38 0.72 0.14 0.30
 Diet3 11 F 1.82 nd nd nd nd 2.57 1.69 0.84 1.33
 Diet4 3 F 8.08 nd nd nd nd 0.78 1.58 0.31 0.18
 Diet6 5 F <0.10 nd nd nd nd 0.28 <0.10 <0.10 <0.10

Table IB.

Analysis of IgE antibodies based on histologic response to cow's milk elimination diet.

Responders n=13 Non-responders n=8 p value
Cow's milk IgE Ab ≤0.35 IU/ml, n (%) 8 (62%) 2 (25%) 0.1
Cow's milk IgE Ab level, IU/ml 0.50 2.6 0.002
Milk component IgE Ab, n/number tested 0/6 3/3 ---
IgE Ab ≥0.35 IU/ml to other foods, n (%)
 Egg 0 4 (50%) ---
 Wheat 2 (15%) 6 (75%) 0.006
 Soy 1 (7.7%) 3 (38%) 0.09
 Peanut 1 (7.7%) 2 (25%) 0.3
IgE Ab levels to other food, IU/ml
 Egg 0.28 0.52 0.1
 Wheat 0.60 0.93 0.7

Ab=antibody

Our results confirm that patients with levels of milk specific IgE less than 0.35 IU/ml, or even undetectable antibodies (i.e. <0.1 IU/ml), can respond to cow's milk elimination diet alone. In addition, the levels of IgE antibodies to cow's milk were paradoxically lower in responders compared with quantities in those children who did not respond to the elimination diet (p=0.01) (Fig 1A). Taken with clear evidence that food can cause eosinophil-rich inflammation in the esophagus, our results are in keeping with a model where the disease is primarily driven by a T cell response, including T cells producing cytokines that are responsible for the eosinophil recruitment. However, we would hypothesize that those T cells produce relatively little IL-4 and IL-13. The evidence that these patients have IgG4 antibodies is in keeping with the production of IL-10 together with IL-4 (4).

Fig 1A.

Fig 1A

Histologic response to cow's milk elimination diet in EoE patients grouped by level of IgE antibodies to milk.

The low levels of IgE antibodies to milk in EoE seem distinct from other food allergy syndromes. Levels of IgE antibodies to peanut or alpha-gal are typically much higher in patients presenting with peanut anaphylaxis or with the alpha-gal syndrome, respectively (5). Instead the low levels of IgE relative to IgG4 ab appear most similar to three different forms of “tolerance”: i) beekeepers who have received multiple stings, ii) individuals who live with a cat, and iii) sustained unresponsiveness in patients treated with peanut orally (6-8). However, the response in EoE cannot be regarded as a form of tolerance since it is clearly associated with a symptomatic form of inflammation in the esophagus.

The low levels of IgE antibodies with increased IgG4 antibodies to milk are in keeping with existing evidence for the pathogenesis of EoE. Prussin and colleagues found that patients with eosinophilic gastrointestinal disease (EGID) had a similar frequency of peanut specific IL-4 producing T cells associated with an increased number of IL-5 producing T cells compared with peanut allergic patients (9). Kottyan et al recently reported gene expression results that are also in keeping with this form of inflammation (10).

Although the results we report are retrospective and need to be confirmed in a larger group of patients, we feel that analysis of levels of IgE antibodies may be useful for patients with EoE. From a clinical standpoint, the data from our studies suggest that IgE antibody levels to milk may be a biomarker that is helpful for predicting response to cow's milk elimination diet with patients with low levels of IgE antibodies having the greatest drop in eosinophils (Fig 1B). The IgE response may also be helpful in identifying the components of cow's milk that are relevant to the immune response, even in those patients who don't have detectable IgE antibody. Our recent paper on component analysis suggests that IgE antibodies to Bos d 4 and Bos d 5 correlate best with IgE to milk in EoE patients (3).

Fig 1B.

Fig 1B

Esophageal eosinophil counts before and after treatment with cow's milk elimination diet in EoE patients grouped by level of IgE antibodies to milk.

Supplementary Material

Fig E1. The correlation between levels of specific IgE antibody to milk and peak esophageal eosinophil counts after treatment with cow's milk elimination diet.

Acknowledgments

Funding: NIH grants K23-AI-059317 and R01-AI-20565

Appendix

Additional Commentary

Although PPI non-responsiveness has been regarded as an important criterion for the diagnosis of EoE, recent evidence has argued against that view (1). That paper argues strongly that the subjects who respond to PPI are genomically and clinically similar to the subjects who do not respond to PPI. Our own data has consistently suggested the immunological responses to food in patients are independent of PPI responsiveness. The importance of the response to cow's milk, was first identified during the successive reintroduction of foods after successful treatment with six food elimination (1-3).

Additional References

  1. Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, Hirano I, Katzka DA, Moawad FJ, Rothenberg ME, Schoepfer A, Spechler SJ, Wen T, Straumann A, Lucendo AJ. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. In press.

  2. Kagalwalla AF, Shah A, Li B, Sentongo TA, Ritz S, Manuel-Rubio M, et al. Indentification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr 2011;53:145-9.

  3. Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R, Liacouras CA. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012;130:461-7.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Kagalwalla AF, Amsden K, Shah A, Ritz S, Manuel-Rubio M, Dunne K, et al. Cow's milk elimination: a novel dietary approach to treat eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2012;55:711–6. doi: 10.1097/MPG.0b013e318268da40. [DOI] [PubMed] [Google Scholar]
  • 2.Kruszewski PG, Russo JM, Franciosi JP, Varni JW, Platts-Mills TA, Erwin EA. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis. Dis Esophagus. 2015 doi: 10.1111/dote.12339. In press. [DOI] [PubMed] [Google Scholar]
  • 3.Erwin EA, Tripathi A, Ogbugu PU, Commins SP, Slack MA, Cho CB, et al. IgE antibody detection and component analysis in patients with eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2015;3:896–904. doi: 10.1016/j.jaip.2015.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147:602–609. doi: 10.1053/j.gastro.2014.05.036. [DOI] [PubMed] [Google Scholar]
  • 5.Commins SP, Satinover SM, Hosen J, Mozena J, Borish L, Lewis BD, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2009;123:426–33. doi: 10.1016/j.jaci.2008.10.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Varga EM, Kausar F, Aberer W, Zach M, Eber E, Durham SR, Shamji MH. Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE. J Allergy Clin Immunol. 2013;131:1419–21. doi: 10.1016/j.jaci.2012.08.037. [DOI] [PubMed] [Google Scholar]
  • 7.Erwin EA, Woodfolk JA, James HR, Satinover SM, Platts-Mills TA. Changes in cat specific IgE and IgG antibodies with decreased cat exposure. Ann Allergy Asthma Immunol. 2014;112:545–50. doi: 10.1016/j.anai.2014.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014;133:468–75. doi: 10.1016/j.jaci.2013.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Prussin C, Lee J, Foster B. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol. 2009;124:1326–32. doi: 10.1016/j.jaci.2009.09.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nature Genetics. 2014;46:895–900. doi: 10.1038/ng.3033. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig E1. The correlation between levels of specific IgE antibody to milk and peak esophageal eosinophil counts after treatment with cow's milk elimination diet.

RESOURCES